Rutgers Cancer insititute — New Brunswick, New Jersey

Rutgers Cancer insititute is a clinical research site located in New Brunswick, New Jersey, United States 08903.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Rutgers Cancer insititute has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Microsatellite Stable Metastatic Colorectal Cancer.

Sponsors: University of Colorado, Denver.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rutgers Cancer insititute?

Rutgers Cancer insititute has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rutgers Cancer insititute conducted?

Rutgers Cancer insititute has 1 clinical trials on record, with 1 currently active. Their work covers Microsatellite Stable Metastatic Colorectal Cancer.

Is Rutgers Cancer insititute accredited by Crixeo Health?

Rutgers Cancer insititute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rutgers Cancer insititute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.